XML 49 R41.htm IDEA: XBRL DOCUMENT v3.26.1

Stock-based Compensation (Tables)

12 Months Ended

Dec. 31, 2025

Schedule of Stock Options Activity

The following table summarized the stock option activity and related information under all stock option plans:

		Number of Options				Weighted- Average Exercise Price				Weighted- Average Remaining Contractual Life (Years)				Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2022			2,686,835			$	3.34				6.77			$	11,593
Exercised			(131,444	)			1.80				—				—
Forfeited			(140,661	)			14.26				—				—
Outstanding as of December 31, 2023			2,414,730			$	2.79				5.73			$	4,004
Exercised			(43,660	)			1.81				—				—
Forfeited			(398	)			2.74				—				—
Outstanding as of December 31, 2024			2,370,672			$	2.81				4.75			$	6,055
Exercised			(54,255	)			2.36				—				—
Outstanding as of December 31, 2025			2,316,417			$	2.81				3.76			$	24,431
Vested and exercisable as of December 31, 2025			2,313,355			$	2.80				3.75			$	24,431
Vested and expected to vest as of December 31,    2025			2,316,417			$	2.81				3.76			$	24,431

Schedule of Fair Value Weighted-Average Assumptions

The Company estimated the fair value of the market-based PBRSUs award on the grant date using the Monte Carlo simulation model with the following assumptions:

Expected term (years)		0.5 - 4.7
Expected volatility			70.9	%
Risk-free interest rate			3.29	%
Dividend yield			0	%
Share price		$	5.10

Schedule of Restricted Stock Activity

The following table summarizes the Company’s RSU activity for the year ended December 31, 2025:

		Shares				Weighted Average Grant Date Fair Value per Share
Outstanding as of December 31, 2022			2,388,909			$	26.11
Granted			5,143,160				6.04
Released			(1,205,704	)			18.87
Forfeited			(1,126,554	)			18.21
Outstanding as of December 31, 2023			5,199,811			$	9.65
Granted			4,502,661				3.57
Released			(1,921,646	)			10.91
Forfeited			(1,230,957	)			7.63
Outstanding as of December 31, 2024			6,549,869			$	5.48
Granted			4,709,367				7.90
Released			(2,799,331	)			6.65
Forfeited			(1,322,632	)			6.13
Outstanding as of December 31, 2025			7,137,273			$	6.51

Summary of Stock-Based Compensation Expense

Total stock-based compensation expense by function was as follows (in thousands):

		Year ended December 31,
		2025				2024				2023
Cost of revenue		$	414			$	279			$	965
Research and development expenses			12,794				16,657				16,760
General and administrative expenses			7,969				5,875				5,131
Sales and marketing expenses			666				897				819
Total		$	21,843			$	23,708			$	23,675

X

- Definition

Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration